Medtronic to join intravascular radiation race with XRT purchase
This article was originally published in Clinica
Executive Summary
Medtronic is poised to enter the emerging market of intravascular radiation for restenosis treatment with the acquisition of private company XRT for an undisclosed sum. All XRT executives will remain with the company, which will become part of Medtronic's vascular unit.